CYD-2-11


CAS No. : 1425944-22-4

1425944-22-4
Price and Availability of CAS No. : 1425944-22-4
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-120275
M.Wt: 358.39
Formula: C22H18N2O3
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 1425944-22-4 :

CYD-2-11 is a selective Bax agonist with a Ki value of 34.1 nM. CYD-2-11 induces cell apoptosis and shows antiproliferative activity to breast cancer MDA-MB-231 and MCF-7 cell lines with IC50 values of 3.22 and 3.81 μM, respectively. CYD-2-11 suppresses tumor growth in MDA-MB-231 tumor models. CYD-2-11 can be used for the research of breast and lung cancer[1][2]. In Vitro:CYD-2-11 (0-100 μM; 48 h) shows anti-proliferation effects to breast cancer cells[1].
CYD-2-11 (5 μM; 48 h) selectively binds to Bax protein and induces apoptosis in NSCLC and SCLC cell lines[2]. In Vivo:CYD-2-11 (20 mg/kg; i.p.; once daily for 7 days) inhibits tumor growth[1].
CYD-2-11 (40 mg/kg; i.p.; once daily for 14 days) represses lung cancer growth and overcomes rapalog resistance with the combination of RAD001 (1 mg/kg) in murine lung cancer models[2].

Your information is safe with us.